Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Assistance Publique -Hopitaux De Paris
París, FranciaPublicaciones en colaboración con investigadores/as de Assistance Publique -Hopitaux De Paris (26)
2024
-
A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis
Journal of Translational Medicine, Vol. 22, Núm. 1
-
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
The Lancet HIV, Vol. 11, Núm. 2, pp. e106-e116
-
Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma
Liver International
-
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis
Journal of Hepatology
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
-
Vena cava replacement and major hepatectomy for liver tumors: international multicenter retrospective cohort study
International journal of surgery (London, England), Vol. 110, Núm. 7, pp. 4286-4296
2023
-
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422
-
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 3, pp. 921-928
-
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106
-
Impact of body mass index on the difficulty and outcomes of laparoscopic left lateral sectionectomy
European Journal of Surgical Oncology, Vol. 49, Núm. 8, pp. 1466-1473
-
Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma
HPB, Vol. 25, Núm. 11, pp. 1302-1322
-
The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry
Thrombosis Research
2022
-
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
Gut, Vol. 71, Núm. 9, pp. 1856-1866
-
Minimally Invasive Donor Hepatectomy for Adult Living Donor Liver Transplantation An International, Multi-institutional Evaluation of Safety, Efficacy and Early Outcomes
Annals of Surgery, Vol. 275, Núm. 1, pp. 166-174
-
What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association
JHEP Reports, Vol. 4, Núm. 12
2021
-
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial
Journal of the National Cancer Institute, Vol. 113, Núm. 7, pp. 917-923
-
Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis
Hepatology International, Vol. 15, Núm. 4, pp. 1006-1017
-
Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study
Gastroenterology, Vol. 160, Núm. 4, pp. 1151-1163.e3
2019
-
Current and innovative emerging therapies for porphyrias with hepatic involvement
Journal of Hepatology, Vol. 71, Núm. 2, pp. 422-433
2017
-
A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases
Hepatology, Vol. 66, Núm. 5, pp. 1644-1661